Abstract CN11
Background
Patients with prostate cancer may experience a worsening in their emotional wellbeing and physical health due to treatments or disease burden. It has been reported that physical activity and lifestyle interventions are associated with improved patient outcomes and a lack of health literacy is perceived by patients as a key burden of their cancer experience, and an improvement in this aspect has been strongly correlated with better overall survival. Voice assistants have emerged as a promising tool to support patients' guided learning and exercises. Here, we report on the development, content, and functionality of the first Amazon Alexa voice assistant for patients living with prostate cancer in Spain.
Methods
A multidisciplinary group of expert physicians on prostate cancer were selected as a scientific committee. Based on their clinical experience and the scientific evidence, the working group agreed on and created the content. The topics for each module were defined through the use of a consensus technique. The digital skill, named ProstaGYM, was endorsed by the national patient association ANCAP and the design and programming was performed by an Amazon developer with support from Bayer Hispania.
Results
The skill contains four content modules: 1) general disease information and healthy lifestyle recommendations, 2) exercise routines to prevent sarcopenia, 3) specific exercises and interventions to manage urinary symptoms, 4) advice on sexual health and psychological support. ProstaGYM is available free of charge on the Spain Amazon Alexa skill store. Since its launch in November 2022, the following information on metrics were obtained (cut-off 30th April 2023): 144 unique customers, 164 user enablements (skill activation) and 182 sessions.
Conclusions
The skill ProstaGYM constitutes an innovative approach to guide patients with prostate cancer to self-manage disease symptoms and treatment side effects and promote physical exercise that may improve their quality of life.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
Bayer Hispania.
Funding
Bayer Hispania.
Disclosure
E. Gallardo: Financial Interests, Institutional, Speaker, Consultant, Advisor, Grant support, Travel/accomodation expenses: Sanofi, Janssen, Astellas, Bayer, Ipsen, Pfizer, Roche, Bristol Myers Squibb; Financial Interests, Institutional, Speaker, Consultant, Advisor: Novartis, EUSA Pharma, MSD, Merck, Rovi, Daiichi Sankyo, Techdow, Lilly, Advanced Accelerator Applications; Financial Interests, Institutional, Speaker, Consultant, Advisor, Travel/Accomodation expenses: Eisai, AstraZeneca; Financial Interests, Institutional, Research Grant, Grant support: Ferrer; Financial Interests, Institutional, Other, Travel/Accomodation expenses: Pierre Fabre. D. Büchser Garcia: Financial Interests, Institutional, Speaker, Consultant, Advisor: Bayer, Astellas, Janssen. L. Regis Placido: Financial Interests, Institutional, Speaker, Consultant, Advisor: Bayer, Recordati. E. Rios Gonzalez: Financial Interests, Institutional, Speaker, Consultant, Advisor: Bayer, Janssen, Recordati, Merck, AstraZeneca; Financial Interests, Institutional, Speaker’s Bureau: Astellas. A. Marco Perez, C. Moretones Agut: Non-Financial Interests, Institutional, Other, Employee: Bayer.
Resources from the same session
CN23 - Understand the patients’ perspectives based on their profile to improve health-related quality of life assessment in breast cancer
Presenter: Cynthia Lesbros
Session: Poster session 25
Resources:
Abstract
CN31 - A qualitative study investigating the perception of simultaneous care in nurses
Presenter: Daniela Tregnago
Session: Poster session 25
Resources:
Abstract
CN32 - Exploring the content and outcomes of meaning-centered interventions in palliative care: A scoping review
Presenter: Yasemin Eskigülek
Session: Poster session 25
Resources:
Abstract
CN33 - Health care professionals’ perceptions regarding shared clinical decision-making in both acute and palliative cancer care, a qualitative study and its clinical implications
Presenter: Helena Ullgren
Session: Poster session 25
Resources:
Abstract
CN34 - Pallium game: The use of a card game in palliative care
Presenter: Bruno Magalhães
Session: Poster session 25
Resources:
Abstract
CN42 - A pharmacist-led interprofessional medication adherence program improved adherence to oral anticancer therapies: The OpTAT randomized controlled trial
Presenter: Carole Bandiera
Session: Poster session 25
Resources:
Abstract
CN43 - Development, implementation and evaluation of a cancer survivorship care program
Presenter: Flore Herman
Session: Poster session 25
Resources:
Abstract
CN45 - Exercise training following surgery and chemotherapy for ovarian cancer: A realist evaluation of a co-designed implementation process
Presenter: deirdre mc grath
Session: Poster session 25
Resources:
Abstract
CN46 - Experiences and sexuality of participants with a permanent colostomy after cancer treatment: A qualitative study
Presenter: kelly Van der Eecken
Session: Poster session 25
Resources:
Abstract
CN48 - Mobile response and prevention unit: Mobile information and management unit a collaboration between “Care In Adult Cancer Patients” nursing research laboratory and “Cancer Guidance Center” a non-profit organization (Kapa3)
Presenter: Evangeli Bista
Session: Poster session 25
Resources:
Abstract